AMBS
Amarantus Bioscience Holdings Inc

229
Loading...
Loading...
Amarantus BioScience Holdings, Inc. is a biopharmaceutical company, which engages in developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. It focuses on acquiring product and technology rights, raising capital, and performing research and development. The company was founded by Gerald E. Commissiong and John W. Commissiong on January 14, 2008 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Amarantus BioScience Holdings Inc?
What is the 52-week high for Amarantus BioScience Holdings Inc?
What is the 52-week low for Amarantus BioScience Holdings Inc?
What is the 50-day moving average of Amarantus BioScience Holdings Inc?

Latest AMBS News

View
No AMBS news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.